ReproCELL Incorporated (4978.T)
JPY 103.0
(0.0%)
JPY 103.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 248.14 Million JPY | 5.9% |
| 2022 | 234.31 Million JPY | -9.6% |
| 2021 | 259.2 Million JPY | -15.47% |
| 2020 | 306.64 Million JPY | 23.37% |
| 2019 | 248.55 Million JPY | 6.22% |
| 2018 | 233.99 Million JPY | -3.7% |
| 2017 | 242.98 Million JPY | -24.52% |
| 2016 | 321.92 Million JPY | 18.22% |
| 2015 | 272.31 Million JPY | 15.93% |
| 2014 | 234.89 Million JPY | 238.38% |
| 2013 | 69.41 Million JPY | 85.89% |
| 2012 | 37.34 Million JPY | -6.61% |
| 2011 | 39.98 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 292 Million JPY | 17.68% |
| 2023 Q3 | 284.95 Million JPY | 26.54% |
| 2023 Q4 | 248.14 Million JPY | -12.92% |
| 2023 Q1 | 241.6 Million JPY | 3.11% |
| 2023 Q2 | 225.18 Million JPY | -6.8% |
| 2023 FY | 248.14 Million JPY | 5.9% |
| 2022 Q3 | 297.51 Million JPY | -19.06% |
| 2022 Q1 | 318.67 Million JPY | 22.95% |
| 2022 FY | 234.31 Million JPY | -9.6% |
| 2022 Q4 | 234.31 Million JPY | -21.24% |
| 2022 Q2 | 367.57 Million JPY | 15.34% |
| 2021 FY | 259.2 Million JPY | -15.47% |
| 2021 Q1 | 229.12 Million JPY | -25.28% |
| 2021 Q2 | 261.66 Million JPY | 14.2% |
| 2021 Q4 | 259.2 Million JPY | -2.6% |
| 2021 Q3 | 266.11 Million JPY | 1.7% |
| 2020 Q3 | 274.78 Million JPY | -10.42% |
| 2020 Q4 | 306.64 Million JPY | 11.6% |
| 2020 FY | 306.64 Million JPY | 23.37% |
| 2020 Q1 | 360.76 Million JPY | 45.15% |
| 2020 Q2 | 306.76 Million JPY | -14.97% |
| 2019 FY | 248.55 Million JPY | 6.22% |
| 2019 Q3 | 209.18 Million JPY | -5.61% |
| 2019 Q4 | 248.55 Million JPY | 18.82% |
| 2019 Q1 | 232.81 Million JPY | -0.5% |
| 2019 Q2 | 221.6 Million JPY | -4.81% |
| 2018 FY | 233.99 Million JPY | -3.7% |
| 2018 Q4 | 233.99 Million JPY | -5.54% |
| 2018 Q3 | 247.7 Million JPY | 0.61% |
| 2018 Q2 | 246.21 Million JPY | -6.53% |
| 2018 Q1 | 263.42 Million JPY | 8.41% |
| 2017 Q3 | 268.99 Million JPY | -5.57% |
| 2017 FY | 242.98 Million JPY | -24.52% |
| 2017 Q1 | 310.39 Million JPY | -3.58% |
| 2017 Q4 | 242.98 Million JPY | -9.67% |
| 2017 Q2 | 284.86 Million JPY | -8.22% |
| 2016 FY | 321.92 Million JPY | 18.22% |
| 2016 Q3 | 303.02 Million JPY | -11.27% |
| 2016 Q4 | 321.92 Million JPY | 6.24% |
| 2016 Q2 | 341.51 Million JPY | 7.25% |
| 2016 Q1 | 318.41 Million JPY | 16.93% |
| 2015 Q2 | 267.26 Million JPY | 25.38% |
| 2015 FY | 272.31 Million JPY | 15.93% |
| 2015 Q1 | 213.16 Million JPY | -9.25% |
| 2015 Q4 | 272.31 Million JPY | -10.38% |
| 2015 Q3 | 303.86 Million JPY | 13.69% |
| 2014 Q3 | 168.94 Million JPY | 83.11% |
| 2014 Q4 | 234.89 Million JPY | 39.03% |
| 2014 Q1 | 61.39 Million JPY | -11.56% |
| 2014 Q2 | 92.26 Million JPY | 50.28% |
| 2014 FY | 234.89 Million JPY | 238.38% |
| 2013 FY | 69.41 Million JPY | 85.89% |
| 2013 Q1 | 58.22 Million JPY | 0.0% |
| 2013 Q2 | 47.53 Million JPY | -18.36% |
| 2013 Q3 | 76.15 Million JPY | 60.2% |
| 2013 Q4 | 69.41 Million JPY | -8.85% |
| 2012 FY | 37.34 Million JPY | -6.61% |
| 2011 FY | 39.98 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 63.67% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -1284.015% |
| GNI Group Ltd. | 2.33 Billion JPY | 89.353% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 88.861% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -267.718% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 77.862% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -139.67% |
| AnGes, Inc. | 1.61 Billion JPY | 84.643% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -235.329% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 91.452% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 22.917% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -134758.696% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -77.066% |
| CanBas Co., Ltd. | 728 Thousand JPY | -33985.165% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -182.417% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -67.731% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -287.072% |
| Kidswell Bio Corporation | 875.65 Million JPY | 71.662% |
| PeptiDream Inc. | 2.4 Billion JPY | 89.679% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -4545.077% |
| Ribomic Inc. | 2.27 Million JPY | -10812.049% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -24813999900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -589.278% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -755.655% |
| CellSource Co., Ltd. | 305.92 Million JPY | 18.889% |
| FunPep Company Limited | 25.54 Million JPY | -871.536% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 31.84% |
| Stella Pharma Corporation | 1.11 Billion JPY | 77.77% |
| TMS Co., Ltd. | 50.02 Million JPY | -396.032% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -1087.216% |
| Cuorips Inc. | 1.04 Million JPY | -23690.988% |
| K Pharma,Inc. | 10.79 Million JPY | -2198.87% |
| Takara Bio Inc. | 11.85 Billion JPY | 97.906% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 44.93% |
| StemCell Institute Inc. | 42.26 Million JPY | -487.147% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -8.564% |
| CellSeed Inc. | 46.19 Million JPY | -437.204% |